Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$10.26
0.121.18%
Last update: Oct 15, 4:00 PM
$10.16
0.020.2%
MoonLake Immunotherapeutics (MLTX) Stock Price, Quote, News & History
MLTXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of MoonLake (NASDAQ:MLTX) through any online brokerage.
Other companies in MoonLake’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
MoonLake has a consensus price target of $38.56.
The stock price for MoonLake (NASDAQ: MLTX) is $10.3 last updated October 15, 2026 at 4:00 PM EDT.
There are no upcoming dividends for MoonLake.
MoonLake does not have any upcoming earnings scheduled.
There is no upcoming split for MoonLake.
MoonLake is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
